Benefit-Risk Assessment of Zaleplon in the Treatment of Insomnia

Author: Barbera Joseph   Shapiro Colin  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.28, Iss.4, 2005-01, pp. : 301-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract